readthroughSign in
CompanyEOLSNasdaqNewport Beach, CA

Evolus, Inc.

Evolus develops aesthetic injectable products including Jeuveau (prabotulinumtoxinA-xvfs), a neurotoxin; Evolysse, hyaluronic acid gels; and Profhilo, an injectable for skin quality.

10-QNov 16Latest SEC filing
Nov 4Latest story